SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zooms Anthropic stake is drawing attention as traders view the company as a potential proxy for Anthropics IPO and debate how much that holding could be worth. Optimists also point to Zooms enterprise and AI progress, while skeptics question whether its core business can grow amid competition and bundled tools.

World Liberty Financial (WLFI) is a cryptocurrency launched in 2025and operates on the Ethereum platform. World Liberty Financial has a current supply of 100,000,000,000 with 31,780,204,530 in circulation. The last known price of World Liberty Financial is 0.04626372 USD and is down -0.64 over the last 24 hours. It is currently trading on 491 active market(s) with $24,976,405.40 traded over the last 24 hours. More information can be found at https://www.worldlibertyfinancial.com/.

WorldFinancial

WLFI discussion centers on repeated rally attempts and speculation that a bank charter and future USD1 utility could support the token, with bullish traders also citing limited circulating supply. Others question the tokens value and criticize its weak performance and perceived Trump-family monetization; the charter-driven optimism remains disputed.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,147,017.33279973 in circulation. The last known price of Hedera is 0.06682956 USD and is down -1.15 over the last 24 hours. It is currently trading on 468 active market(s) with $27,520,153.09 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBARs prolonged decline and sharp swings are driving debate, with bearish traders calling it a failed or manipulated project and pointing to token supply and weak demand, while holders view lower prices as a chance to accumulate. No listed article directly verifies a dominant catalyst.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Healths stronger-than-expected quarterly results and raised outlook sparked a sharp, high-volume rally, with traders also citing the share-repurchase authorization and planned repayment of debt. The reaction is broadly bullish, though some traders remain cautious about the companys heavy debt and whether the gains will hold; speculation about Bausch + Lomb remains a secondary theme.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Early ACR data for CRISPRs off-the-shelf CAR-T therapy zugo-cel, including responses in systemic sclerosis and inflammatory myopathy, is drawing attention. Traders are encouraged by the signal but note the small patient groups and outstanding safety and durability questions; separately, Novartis Lp(a) trial outcome has raised questions about CTX321s potential to reduce cardiovascular events.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

Traders are discussing onsemis reported cancellation of its planned Czech silicon-carbide facility, alongside concerns that softer automotive and industrial demand is leaving capacity chasing fewer orders. Some argue AI data-center power demand could help offset that weakness, while others doubt it can make up for pressure in the companys core markets.

Shiba Inu (SHIB) is a cryptocurrency launched in 2020and operates on the Ethereum platform. Shiba Inu has a current supply of 589,495,714,214,776.34846852 with 589,238,178,269,145.82508425 in circulation. The last known price of Shiba Inu is 0.00000448 USD and is down -1.57 over the last 24 hours. It is currently trading on 1126 active market(s) with $30,738,778.29 traded over the last 24 hours. More information can be found at https://shibatoken.com/.

Shiba Inu

SHIBs choppy, largely range-bound trading is driving discussion, with repeated chart posts flagging bearish shifts and consolidation. Some holders are buying dips and anticipating a breakout, while skeptics point to weak momentum and question the tokens utility and burn efforts.

OpenAI

Speculation that OpenAI may delay its IPO amid tech-market volatility is driving discussion, with traders debating whether weaker listing conditions could temper demand or simply postpone a highly anticipated public debut. The conversation also reflects broader scrutiny of OpenAIs valuation and capital needs.

Hyperliquid (HYPE) is a cryptocurrency and operates on the Hyperliquid platform. Hyperliquid has a current supply of 950,035,436.93490335 with 253,066,073.62416895 in circulation. The last known price of Hyperliquid is 77.55863812 USD and is down -1.57 over the last 24 hours. It is currently trading on 351 active market(s) with $519,678,816.00 traded over the last 24 hours. More information can be found at https://hyperliquid.xyz/.

Hype

HYPE is drawing attention after a sharp rally toward record levels, with traders tying the bullish case to Hyperliquids fee-funded buybacks and burns, tokenization growth, and potential regulated U.S. access through partners. Many expect further gains, while others warn of volatility, resistance, and possible pullbacks.

NEAR Protocol (NEAR) is a cryptocurrency launched in 2020. NEAR Protocol has a current supply of 1,311,114,800. The last known price of NEAR Protocol is 3.70158857 USD and is down -0.46 over the last 24 hours. It is currently trading on 688 active market(s) with $312,860,507.90 traded over the last 24 hours. More information can be found at https://near.org/.

Near

NEARs recent weakness and shifting buying-versus-selling flows dominate the discussion, with traders debating whether the pullback is a buying opportunity or a sign of further downside. Some cite whale accumulation and technical support, while others remain bearish and expect more selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
